![Michael Levy, MD, PhD Profile](https://pbs.twimg.com/profile_images/1089321982355750912/6hyy3vu8_x96.jpg)
Michael Levy, MD, PhD
@mlevy18
Followers
865
Following
1
Statuses
34
Associate Professor, Harvard Medical School Director, Neuroimmunology Clinic and Research Laboratory Department of Neurology, Massachusetts General Hospital
Boston, MA
Joined April 2009
My fellow, @AVishnevetsky spends most of her time solving NMO and MOG. But in her spare time, she also saves Ukranian families!
0
2
26
2022 Massachusetts Walk-Run-N-Roll for SRNA : Make a donation today to support 2022 Massachusetts Walk-Run-N-Roll for SRNA #Massachusetts-walkrunnroll-for-srna via @raisely
0
0
5
#MedTwitter Postdoctoral Fellowship Opportunity - Neuroimmunology in Autism at Harvard/Mass General Contact: mlevy11@mgh.harvard.edu
1
7
33
I recently recorded another podcast - How to avoid a misdiagnosis - MS, NMOSD & MOGAD. @wearesrna @TheSumairaFDN @guthyjacksonfdn
0
10
40
Hear my update on our MOG Initiative at MGH, and learn about the first-ever MOG Antibody Disease trial: @MGHNeurology @TheMOGProject @TheSumairaFDN
0
7
25
The MGH NMO Clinic and Research Lab announces 2 grants from the Sumaira Foundation! - to examine how cholesterol pathways influence MOG-AD activity - to create a simple, inexpensive NMO test for use in developing countries #mghneurology #NMO #MOG #sumairafoundation
3
3
19
Do you or anyone you know have MOG antibody disease? Take this survey to help us assess the most effective treatments: @MGHNeurology
3
11
14
I am pleased to introduce the Superficial Siderosis Clinic and Research Laboratory at Massachusetts General Hospital. Please visit our new web page: @MGHNeurology
1
1
12
The Massachusetts General Hospital NMO Clinic and Research Laboratory website is now available in Mandarin and Spanish! See options in the right-hand bar. @MGHNeurology
0
1
6
MGH is the first site for Alexion’s Ultomiris trial in NMOSD. Ultomiris is a long acting version of Soliris, which requires an infusion every 2 weeks. Ultomiris would extend that to 8 weeks. The goal is to show that Ultomiris is as effective as Soliris. mlevy11@mgh.harvard.edu.
4
7
19
Take advantage of this #GivingTuesday to make a donation to the new NMO Clinic and Research Lab at Mass General Hospital! Thank you for all you do! #mgh
0
8
10